Device / Technology News

RSS

New photothermal therapy overcomes major cancer treatment barriers

In a promising development for cancer treatment, a collaborative research team has overcome two issues that have prevented photo thermal therapy, a much less invasive treatment option than surgery and/or radiation, from becoming more common.

22 Jul 2026

arcoris bio and Europa Biosite partner to bring immunoMUSE® kits to Europe and North American market

arcoris bio, a Swiss life science research tools and in vitro diagnostics company, today announced a distribution partnership with Europa Biosite, a leading distributor of life science research products and services.

From arcoris bio AG 21 Jul 2026

Simple changes to surgical tools may reduce swallowing complications after neck surgery

Rice University mechanical engineers and Baylor College of Medicine neurosurgeons have identified simple changes to surgical tools that could reduce strain on the esophagus and potentially lower the risk of swallowing difficulties after neck surgery.

21 Jul 2026

Human experts remain essential for checking clinical AI outputs

In a Rwanda-based evaluation, LLM judges produced consistent and far cheaper ratings of clinical AI responses but matched local clinician ratings on only a minority of assessment criteria. They consistently missed potential demographic bias, indicating that human expert evaluation remains important despite AI’s potential role in initial screening.

21 Jul 2026

UVA researcher wins federal grant to develop tools for studying rare circulating cells

A University of Virginia School of Engineering and Applied Science faculty researcher earned a major new federal grant to develop emerging tools to work with some of the rarest circulating cells in the human body, a step toward better treatments for diseases such as cancer and infection.

21 Jul 2026

Automated workflow speeds bacterial sample preparation for genetic sequencing

Biomedical engineers at Brown University have developed a fully automated workflow that simplifies and accelerates the preparation of bacterial samples for genetic sequencing.

21 Jul 2026

AI-powered PeptiVerse could accelerate peptide drug discovery

Penn Engineers have developed PeptiVerse, an AI-powered platform that predicts key chemical and biological properties of peptides, the strings of amino acids whose medical potential has been demonstrated by the success of GLP-1 drugs, the widely used weight-loss treatments.

21 Jul 2026

New light-sheet imaging system tracks brain seizure dynamics in 3D

Seizures can race through the brain in seconds, making them difficult to capture in detail. To overcome this challenge, researchers have developed a new high-resolution light-sheet imaging system that is fast enough to image seizure propagation in the brain of a larval zebrafish in 3D.

21 Jul 2026

New AI framework prioritizes high quality patient care in hospitals

A UVA Health emergency medicine doctor and colleague at Clemson University have developed a framework to help hospitals integrate artificial intelligence to not just increase efficiency and cut costs but ensure high-quality patient care remains the top priority.

21 Jul 2026

UC San Diego and IGI join hands to develop advanced genome-editing tools and applications

The University of California San Diego and the Innovative Genomics Institute (IGI), founded by Nobel laureate and CRISPR gene editing co-discoverer Jennifer Doudna, announced a new partnership today to jointly develop cutting-edge genomic tools for addressing large-scale challenges in health and the environment.

21 Jul 2026

Fairjourney Bio announces scientific program and leadership for The Antibody Series 2026

FairJourney Bio ("FJBio"), a global antibody discovery expert, has announced the program for The Antibody Series (TAS) 2026, which will explore how insights from natural antibody repertoires, advances in computational design, and novel engineering strategies are transforming the discovery and development of antibody therapeutics.

From FairJourney Biologics 21 Jul 2026

New AI score enhances monitoring of myelodysplastic neoplasms

Weill Cornell Medicine investigators have developed a new AI-based method to assess patients with a form of blood cancer called myelodysplastic neoplasms.

20 Jul 2026

Machine learning tool improves accuracy of genome mapping studies

University of Virginia School of Medicine scientists have identified a widespread source of error in a popular method for studying the genome – our genetic instructions – and created a machine-learning tool to correct it.

20 Jul 2026

New tumor organoids strengthen precision oncology research

Significant advances have been made in the development of patient-derived tumor "organoids" for preclinical research, in two new studies led by Weill Cornell Medicine investigators.

20 Jul 2026

Dissolving microneedles could improve photodynamic skin cancer treatment

Photodynamic therapy (PDT) uses a light-sensitive drug and a specific wavelength of light to destroy cancer cells.

20 Jul 2026

AI-guided technique improves targeted therapy delivery for brain tumors

Researchers presented a groundbreaking artificial intelligence (AI)-guided technique today at the Society of NeuroInterventional Surgery's (SNIS) 23rd Annual Meeting that may improve the accuracy of delivering experimental therapies directly to malignant brain tumors.

20 Jul 2026

New tool detects hidden biases in medical training data

Researchers have built a tool to uncover hidden issues in the massive datasets used to train medical AI.

20 Jul 2026

AI may predict harmful chemical exposures affecting human health

Artificial intelligence is rapidly improving scientists' ability to detect chemicals in the environment and human body.

19 Jul 2026

New portable strip test accurately detects mosquito-borne viruses

A research team has developed a multisite bridging-mediated lateral flow immunoassay (mbLFIA) that enables highly sensitive, portable detection of mosquito-borne viruses, using Chikungunya virus (CHIKV) as a model target.

17 Jul 2026

NIH grant supports AI development for glaucoma prognosis and care

The National Eye Institute (NEI) and National Institutes of Health (NIH) awarded Mingquan Lin, PhD, an assistant professor in the Division of Computational Health Sciences at the University of Minnesota Medical School, a 5-year, $3.7 million grant for his research on Developing Robust Multimodal AI for Primary Open-Angle Glaucoma Prognosis.

17 Jul 2026